Clinical Trials

35 enrolled

Melanoma

NCT06556004 2024-08-15

Trimelvax001

20 enrolled

Melanoma

NCT06270706 2024-06-12

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologic

77 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05075356 2024-05-14

iToBoS

600 enrolled

Disease, Melanoma

NCT02232516 2024-04-10

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

30 enrolled 17 charts

DermatologicLymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT06342297 2024-04-02

Dermatoscopy Guided Resection for Skin Cancer

400 enrolled

Margins of Excision, Carcinoma, Basal Cell

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06320353 2024-03-20

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

266 enrolled

Melanoma, Neoplasms

NCT06307093 2024-03-12

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

DermatologicHead & NeckThoracic

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT05942794 2024-02-28

Identification of Oral Lesions Through an Autofluorescence System

200 enrolled

DermatologicHead & Neck

Carcinoma, Squamous Cell, Keratosis, Leukoplakia, Oral, Lichen Planus, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral

NCT06151847 2024-02-28

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

12 enrolled

Melanoma

NCT06271603 2024-02-22

ECOBASO

704 enrolled

Carcinoma, Basal Cell

NCT05135715 2024-02-20

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

50 enrolled

Melanoma

NCT06254547 2024-02-12

Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App

150 enrolled

Melanoma, Skin Neoplasms

NCT04702854 2024-02-09

BMUMM

Melanoma

NCT04137900 2024-02-05

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

DermatologicLymphoidThoracic

499 enrolled

Carcinoma, Non-Small-Cell Lung, Lymphoma, Melanoma, Neoplasm Metastasis

NCT06239623 2024-02-02

ERK Inhibitor JSI-1187 in Advanced Solid Tumors

Melanoma

NCT06236360 2024-02-01

MINI-MD

30 enrolled

Melanoma, Neoplasm Metastasis

NCT06227416 2024-01-26

Skin Tumor Biomarkers by Mass Spectrometry Imaging

300 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Skin Neoplasms

NCT03068624 2024-01-25

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

34 enrolled

Uveal Melanoma

NCT06145464 2024-01-17

Shadow4All

Literacy, Skin Neoplasms

NCT06207747 2024-01-17

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

70 enrolled

Melanoma

NCT04253080 2024-01-09

ENZYMELA

170 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT04720768 2024-01-05

CELEBRATE

78 enrolled

Melanoma, Neoplasm Metastasis

NCT06150144 2024-01-02

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

40 enrolled

Carcinoma, Basal Cell

NCT05022901 2023-12-21

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

30 enrolled

Uveal Melanoma

NCT03638375 2023-12-12

ACTME

34 enrolled

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT02557321 2023-11-21

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

50 enrolled

Melanoma

NCT05451680 2023-11-21

Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg

20 enrolled

Skin Neoplasms

NCT05456334 2023-11-21

New Treatments for Actinic Keratoses of the Scalp

120 enrolled

Keratosis, Actinic

NCT02977052 2023-11-15

OpACIN-neo

186 enrolled

Melanoma

NCT05234658 2023-11-08

Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

21 enrolled

Carcinoma, Basal Cell

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

DermatologicHead & NeckSarcomaThoracic

172 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT05370807 2023-10-24

RegoMel

48 enrolled

Melanoma

NCT04670445 2023-10-23

UPLIFT

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

210 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Melanoma, Mesothelioma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms

NCT04201223 2023-10-18

FLARE

762 enrolled

Melanoma

NCT06080711 2023-10-12

AIDMel

30 enrolled

Melanoma, Skin Neoplasms

NCT04362722 2023-10-10

DUNCAN

40 enrolled

Carcinoma, Carcinoma, Basal Cell

NCT05329792 2023-10-06

IntriNSiC

70 enrolled

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Sarcoma, Kaposi, Carcinoma, Merkel Cell

NCT04546074 2023-10-03

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

22 enrolled

Melanoma

NCT01586767 2023-09-21

Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

45 enrolled

CNSDermatologic

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Carcinoma, Adenoid Cystic, Fistula, Melanoma, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory

NCT04986696 2023-09-21

IMPulse

46 enrolled

Disease, Melanoma

NCT05781386 2023-09-21

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

255 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT05986331 2023-09-21

Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma

366 enrolled

Melanoma

NCT06037239 2023-09-14

Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study

53 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT02858921 2023-08-30

Neo Trio

Phase EARLY_PHASE1 Unknown

Melanoma, Neoplasms

NCT05932511 2023-08-30

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

15 enrolled

Carcinoma, Squamous Cell, Skin Neoplasms, Neoplasms, Squamous Cell

NCT03808441 2023-08-25

CAcTUS

21 enrolled